64 participants
A Phase 1a/1b Study to Investigate the Safety, Tolerability, Microbiological Response, and Pharmacokinetics of Inhaled Rev-56 in Adult Healthy Volunteers and Adult Non-cystic Fibrosis Bronchiectasis (NCFB) Patients With Chronic P. Aeruginosa
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-07-28
- Start Date:
- 2026-07-13
- Completion:
- 2027-06-30
Conditions
- Healthy Participants
- Non-cystic Fibrosis Bronchiectasis
Interventions
- COMBINATION_PRODUCT
- DRUG
No Results Yet